Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2022, ended Dec 31, 2022 | $108B |
| FY2023, ended Dec 31, 2023 | $121B |
| FY2024, ended Dec 31, 2024 | $159B |
| FY2025, ended Dec 31, 2025 | $349B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $312B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2022, ended Dec 31, 2022 | $17.9B |
| FY2023, ended Dec 31, 2023 | $17.9B |
| FY2024, ended Dec 31, 2024 | $20.4B |
| FY2025, ended Dec 31, 2025 | $24.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $27.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2022, ended Dec 31, 2022 | $5.18B | $4.42B |
| FY2023, ended Dec 31, 2023 | $5.50B | $3.82B |
| FY2024, ended Dec 31, 2024 | $6.37B | $4.70B |
| FY2025, ended Dec 31, 2025 | $5.55B | $3.55B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.58B | $3.52B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2022, ended Dec 31, 2022 | $7.43B |
| FY2023, ended Dec 31, 2023 | $8.74B |
| FY2024, ended Dec 31, 2024 | $12.8B |
| FY2025, ended Dec 31, 2025 | $11.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $10.5B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2022, ended Dec 31, 2022 | — |
| FY2023, ended Dec 31, 2023 | $7.92B |
| FY2024, ended Dec 31, 2024 | $12.3B |
| FY2025, ended Dec 31, 2025 | $12.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $12.7B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 113% since FY22.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2022, ended Dec 31, 2022 | 152M |
| FY2023, ended Dec 31, 2023 | 149M |
| FY2024, ended Dec 31, 2024 | 155M |
| FY2025, ended Dec 31, 2025 | 326M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 325M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2022, ended Dec 31, 2022 | $2.33B | $708M | $0 |
| FY2023, ended Dec 31, 2023 | $1.88B | $630M | $0 |
| FY2024, ended Dec 31, 2024 | $1.93B | $753M | $5.90B |
| FY2025, ended Dec 31, 2025 | — | $1.31B | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $1.46B | — |
Valuation
At current price- Market Cap
- $369B
- P/E
- 56.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 13.5×
- Price / Book
- 6.4×
- EV / EBITDA
- 35.8×
Growth
Trailing 12 months- Revenue (TTM)
- $27.3B
- Revenue Growth YoY
- 26.5%
- Revenue CAGR 3Y
- 10.7%
- Revenue CAGR 5Y
- —. Compound annual growth over the last 5 fiscal years
- EPS Growth YoY
- 0.9%
- Net Income Growth YoY
- 2.7%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 32.6%
- Net Margin
- 24.1%
- FCF Margin
- 12.9%
- Return on Equity
- 12.3%
Earnings
Trailing 12 months- Net Income
- $6.58B
- EPS (diluted)
- $41.73
- EBITDA
- $10.4B
- Operating Income
- $8.89B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $10.5B
- Total Debt
- $12.7B
- Net Debt
- $2.25B
- Total Assets
- $176B
- Total Liabilities
- $111B
- Shareholders' Equity
- $57.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.94B
- Capital Expenditure
- $423M
- Free Cash Flow
- $3.52B
Dividends and risk
Last 12 months- Dividend Yield
- 2.0%
- Dividend / Share
- $22.40
- Beta (5Y)
- 1.41
Every ratio is calculated from the company’s reported figures.